We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

(HealthDay News) — For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment (MIDAS) scores, according ...

With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...

Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...

You've heard nuts are healthy, but which pack the greatest nutritional bang? Experts list the healthiest nuts to eat ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...